ANDREA SEMONES: Open Payments
NPI 1932539053 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 63 payments from 12 companies in 2025. Trend: 2023 $302 · 2024 $980 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $271 |
| Otsuka America Pharmaceutical, Inc. | 13 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $147 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 4 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, INGREZZA, UZEDY, HETLIOZ, Jornay PM.
Industry payments across KY — which companies pay providers there.
